Profile data is unavailable for this security.
About the company
MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.
- Revenue in USD (TTM)334.51m
- Net income in USD71.52m
- Incorporated2008
- Employees895.00
- LocationMiMedx Group Inc1775 W Oak Commons Court, NeMARIETTA 30062United StatesUSA
- Phone+1 (770) 651-9100
- Fax+1 (678) 384-6720
- Websitehttps://mimedx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Treace Medical Concepts Inc | 187.12m | -49.53m | 688.73m | 516.00 | -- | 4.98 | -- | 3.68 | -0.8154 | -0.8154 | 3.08 | 2.23 | 0.9107 | 1.45 | 5.56 | 362,631.80 | -24.10 | -- | -29.51 | -- | 81.20 | -- | -26.47 | -- | 3.76 | -- | 0.2776 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| Atrion Corp | 169.33m | 19.41m | 734.25m | 712.00 | 37.86 | 3.02 | 21.28 | 4.34 | 11.02 | 11.02 | 96.13 | 138.01 | 0.6444 | 1.44 | 7.21 | 237,817.40 | 7.39 | 11.96 | 7.85 | 12.62 | 36.84 | 41.99 | 11.46 | 19.05 | 2.57 | 92.92 | 0.00 | 42.42 | -7.73 | 2.12 | -44.55 | -10.74 | 4.98 | 11.27 |
| Silk Road Medical Inc | 185.49m | -53.42m | 810.93m | 474.00 | -- | 5.51 | -- | 4.37 | -1.37 | -1.37 | 4.76 | 3.73 | 0.7247 | 2.08 | 7.87 | 391,322.80 | -20.87 | -29.02 | -22.75 | -32.98 | 73.31 | 72.91 | -28.80 | -46.84 | 9.62 | -- | 0.34 | -- | 27.77 | 38.66 | -1.33 | -- | -7.92 | -- |
| Orthopediatrics Corp | 161.83m | -21.97m | 825.38m | 247.00 | -- | 2.20 | -- | 5.10 | -0.9647 | -0.9647 | 7.11 | 15.74 | 0.3748 | 0.4247 | 5.13 | 655,178.10 | -5.09 | -5.40 | -5.62 | -5.93 | 74.07 | 75.09 | -13.58 | -15.92 | 1.99 | -- | 0.0271 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
| Cytek Biosciences Inc | 193.01m | -12.15m | 837.47m | 676.00 | -- | 2.12 | -- | 4.34 | -0.0887 | -0.0887 | 1.43 | 3.01 | 0.3807 | 1.53 | 3.68 | 285,523.70 | -2.40 | -- | -2.67 | -- | 56.69 | -- | -6.29 | -- | 5.89 | -- | 0.0056 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
| BioLife Solutions Inc | 143.27m | -66.43m | 842.58m | 409.00 | -- | 2.49 | -- | 5.88 | -1.52 | -1.52 | 3.28 | 7.48 | 0.332 | 2.46 | 5.45 | 350,298.30 | -15.40 | -13.76 | -17.12 | -15.04 | 32.63 | 36.76 | -46.36 | -42.99 | 1.83 | -30.52 | 0.0733 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
| Paragon 28 Inc | 216.39m | -47.84m | 873.00m | 430.00 | -- | 4.91 | -- | 4.03 | -0.5819 | -0.5819 | 2.64 | 2.15 | 0.7276 | 0.5484 | 5.77 | 503,230.20 | -16.09 | -- | -20.14 | -- | 79.85 | -- | -22.11 | -- | 2.30 | -7.22 | 0.3832 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
| Avanos Medical Inc | 680.10m | -1.60m | 896.96m | 3.77k | -- | 0.7331 | 20.48 | 1.32 | -0.0315 | -1.33 | 14.62 | 26.65 | 0.4005 | 1.62 | 5.48 | 180,350.00 | -0.0942 | -0.6527 | -0.1055 | -0.7338 | 56.33 | 54.45 | -0.2353 | -1.60 | 1.47 | 4.85 | 0.1257 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
| Artivion Inc | 368.21m | -9.56m | 991.44m | 1.50k | -- | 3.36 | 72.76 | 2.69 | -0.261 | -0.261 | 8.64 | 7.07 | 0.4779 | 1.64 | 5.37 | 245,470.70 | -1.25 | -2.20 | -1.33 | -2.36 | 64.75 | 65.51 | -2.61 | -5.34 | 4.26 | 0.9074 | 0.5176 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| AtriCure Inc | 414.60m | -37.23m | 1.06bn | 1.20k | -- | 2.32 | -- | 2.55 | -0.8005 | -0.8005 | 8.92 | 9.43 | 0.7059 | 1.70 | 8.21 | 345,501.70 | -6.34 | -3.72 | -7.08 | -4.10 | 75.26 | 74.36 | -8.98 | -7.64 | 2.83 | -10.27 | 0.1212 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
| MiMedx Group Inc | 334.51m | 71.52m | 1.08bn | 895.00 | 19.35 | 6.91 | 13.50 | 3.22 | 0.3767 | 0.3393 | 2.15 | 1.06 | 1.72 | 2.82 | 6.58 | 373,754.20 | 41.80 | -4.14 | 53.13 | -5.90 | 83.50 | 83.61 | 24.36 | -2.70 | 2.71 | 9.00 | 0.111 | -- | 20.03 | -2.19 | 310.29 | -- | -26.47 | -- |
| Perspective Therapeutics Inc | 1.43m | -37.46m | 1.08bn | 116.00 | -- | 6.90 | -- | 753.44 | -0.1399 | -0.1738 | 0.0054 | 0.2668 | 0.0184 | -- | 0.3321 | 12,362.07 | -48.02 | -- | -54.42 | -- | 102.72 | -- | -2,611.93 | -- | -- | -- | 0.0224 | -- | -- | -- | -- | -- | -- | -- |
| Coretag Inc | 0.00 | -39.35k | 1.13bn | -- | -- | -- | -- | -- | -0.4372 | -0.4372 | 0.00 | -0.93 | 0.00 | -- | -- | -- | -78,700.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 10.95 | -- | -- | -- |
| Adapthealth Corp | 3.25bn | -695.41m | 1.31bn | 10.70k | -- | 0.8886 | -- | 0.4025 | -5.18 | -5.18 | 24.27 | 10.98 | 0.6637 | 21.81 | 8.30 | 303,555.90 | -14.15 | -4.34 | -15.81 | -4.89 | 17.87 | 18.28 | -21.32 | -6.47 | 1.11 | 2.12 | 0.6025 | -- | 7.73 | -- | -1,169.99 | -- | -- | -- |
| Owens & Minor, Inc. | 10.42bn | -38.77m | 1.45bn | 13.70k | -- | 1.62 | 5.75 | 0.1388 | -0.5099 | -0.5099 | 136.98 | 11.71 | 1.98 | 6.79 | 14.60 | 760,861.20 | -0.7372 | 1.32 | -1.11 | 2.07 | 20.75 | 16.48 | -0.3719 | 0.5614 | 0.5648 | 2.19 | 0.7065 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
Data as of May 07 2024. Currency figures normalised to MiMedx Group Inc's reporting currency: US Dollar USD
22.17%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2023 | 8.24m | 5.61% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 6.37m | 4.34% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 4.09m | 2.78% |
| Paradigm Capital Management, Inc.as of 31 Dec 2023 | 3.43m | 2.33% |
| Geode Capital Management LLCas of 31 Dec 2023 | 2.54m | 1.73% |
| Cannell Capital LLCas of 31 Dec 2023 | 2.48m | 1.69% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 1.48m | 1.01% |
| Richmond Brothers, Inc.as of 31 Dec 2023 | 1.40m | 0.96% |
| Divisadero Street Capital Management LPas of 31 Dec 2023 | 1.29m | 0.88% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 1.25m | 0.85% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
